Aim: To characterise systematic reviews and meta-analyses on pharmacist care activities (PCAs) by means of bibliometric indicators. Data sources: The MEDLINE, EMBASE and LILACS databases were consulted. Study selection: Articles describing/evaluating PCAs in any setting (community, ambulatory or hospital) in which research design was a systematic review of the literature (SR) or a meta-analysis (MA) were included. Results: Of the 1180 publications retrieved from the search, 86 were included. The included papers were published between 1998 and 2014. SRs were the most frequent research design (84.9%). The most frequent settings were all-care settings (n = 20, 23.3%), followed by community settings (n = 19, 22.1%). The most common target population included all types of population groups together (n = 53; 59.3%). None of the SR/MAs had a high quality level. The bibliometric analysis showed that the SR/MAs were carried out by an average of four authors (range 1-13) and 62.8% (54/86) of the analysed SR/MAs were written only by pharmacists. The USA and the UK were the most frequent authors' countries of origin. The 86 SR/MAs were published in 49 journals, and the average impact factor was 1.172 (range: 5.827-0.109).
INTRODUCTION
Pharmacist care activities (PCAs) have been recognised as an important part of the population's health care since the 1960s with the emergence of the clinical pharmacy movement at the University of San Francisco in the USA. 1 Since then, the definition of PCAs has changed over time: in the 1990s in the USA, the activities of the pharmacist, focused on the patient, gave rise to the concept of pharmaceutical care (PC), which was defined by Hepler and Strand as '. . .the responsible provision of drug therapy for the purpose of achieving definite outcomes that improve a patient's quality of life'. 2 This concept was quickly extended to other countries. 3 Since its publication, the concept of PC has raised much discussion, [4] [5] [6] [7] [8] [9] and currently, in the literature, different terms have been used to describe PCAs, including 'drugtherapy follow-up', 'pharmaceutical assistance', 'pharmaceutical performance', 'medication therapy management (MTM)', and 'cognitive pharmacy services', among others. 10 In 2011, the International Pharmaceutical Federation (FIP) and the World Health Organization (WHO) defined the aim of pharmacy practice as 'to contribute to health improvement and to help patients with health problems to make the best use of their medicines'. Although this goal is shared in all PCAs, there is no document that attempts to put together the different terms referring to PCAs. 11 Despite this omission from the literature, the number of papers on PCAs has grown exponentially since the 1990s. The results of a quick search in PubMed using the terms 'pharmaceutical services' [MeSH] OR 'pharmaceutical care' OR 'drug therapy management' showed that since 2002 more than 1500 papers on PCAs have been published per year. Due to the large amount of available information, there is a need to measure and characterise the scientific publications on the topic through bibliometric indicators such as the number of published articles, the countries, the institutions, the research groups and researchers involved in the area, the number of citations, among others.
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On the other hand, some of the available information about PCAs has been compiled and analysed in systematic reviews (SRs) and/or meta-analyses (MAs). Both SRs and MAs are important as they aim to gather all the empirical evidence meeting eligibility criteria previously established in order to answer a specific research question. Furthermore, MAs allow the attainment of more accurate estimates of the effects on health care than those derived from studies included in a review using statistical methods. 13, 14 Within this framework, this review aims to characterise systematic reviews and meta-analyses on PCAs by using bibliometric indicators.
METHODS
A systematic review was carried out in the MEDLINE, EMBASE and LILACS databases using the search equations described in Table 1 , without date restriction. This first search was complemented by a review of the references of the retrieved articles, and then the references of the latter were reviewed, and so forth until exhaustion of the strategy. Then, a manual search was also performed for publications specific to the topic and possibly not listed in the indexes of the electronic databases used (i.e. pharmacy cognitive services, pharmacist interventions, etc.). Finally, the 'snowball' technique was used through links of related articles available in the databases. The present review included articles describing or evaluating the pharmacist's care activities in any setting (community, ambulatory or hospital) in which research design was a systematic review of the literature or a meta-analysis. The review excluded the studies in which the intervention: (i) was not performed exclusively by a pharmacist; (ii) when it was performed by pharmacy students; or (iii) when such information was not evident. Two independent reviewers selected the articles; in case of disagreement, the reviewers discussed and if they did not arrive at a consensus, a third reviewer would make the inclusion decision. For the study selection, first, titles and abstracts were reviewed and, in case of doubt, the article was set aside for the second step, which consisted of reading the full text. The entire selection process was registered in the incident record of the review.
Data were extracted from the included SR/MAs using a pre-piloted Microsoft Excel file format. The data extraction from each article was carried out by two independent reviewers who resolved occasional disagreements through the participation of a third reviewer.
The variables analysed were: publication year, study setting (hospital, ambulatory or community), terms used to describe PCAs, target population, experimental designs (observational or experimental studies) and number of included studies. The quality of the SR/MAs was also analysed using AMSTAR -a measurement tool for the Assessment of Multiple Systematic Reviews. 15 Three quality evaluation categories were defined according to the number of criteria met: poor (0-4), moderate (5) (6) (7) (8) and high (9) (10) (11) . Furthermore, other bibliometric indicators were analysed such as the number of authors, field and country of origin, the number and type of participating institutions, the journals in which the reviews were published and their impact factor according to SCImago Journal & Country Rank. 16 
RESULTS
Of the 1180 publications found, 86 were included in this analysis: 73 (84.9%) SRs and 13 (15.1%) MAs. Figure 1 describes the selection process. Table S1 contains summary tables with information of the studies included in the present review.
The SR/MAs analysed were published between 1998 and 2014. Since 2005 there has been a marked growth in the number of publications. The most frequent setting considered in the RS/MAs was a combination of all-care settings (n = 20, 23.3%), followed by community settings (n = 19, 22.1%) and ambulatory settings (n = 19, 22.1%). Hospital settings and a combination of two settings were identified in 14 publications (16.3%), respectively. The most frequent terms used to describe PCAs were 'pharmaceutical care', 'clinical pharmacy' or 'medication management'. These terms were used in 55% (11/20) A combination of all types of population groups was the most frequent target population in the SR/MAs (n = 53; 59.3%), while 32 SR/MAs (37.2%) included only studies in which the target population was adult and elderly patients. The paediatric population was the least studied, with only one SR (1.2%).
Of Regarding the authors' countries of origin, in 88.4% (76/86) of the SR/MAs the authors were from the same country, while in the remaining 11.6% (10/86) they were from two or three different countries. In total, 98 authors were identified, most of them from the USA (n = 26; 26.5%), the UK (n = 19; 19.4%), Australia (n = 11; 11.3%), Canada (n = 11; 11.3%) and Brazil (n = 7; 7.1%). As for the institutions to which the authors belong, 187 different institutions were identified, most of them being universities (n = 129; 69%) and public research institutions (n = 18; 9.6%). in 24 SR/MAs (18%) two or more institutions worked collaboratively.
The Finally, regarding the language of the SR/MAs, the results showed a predominance of the English language with 81 studies (94.2%), and little participation of the Portuguese language with two studies (2.33%) and the French, Spanish and Japanese languages with one study each (1.2%).
DISCUSSION
One of the main difficulties encountered in the topic review was the identification of studies related to PC in the MEDLINE database, since the term 'pharmaceutical care' is not indexed or defined in the dictionary or thesaurus of the MeSH database. According to Van Mil and Fern andez, several attempts have been made to include that term, but they have all been unsuccessful. 5 As mentioned by these same authors, the term 'medical care' is not indexed either, and the definition of 'care' related to other health professions varies widely. The LILACS database provides a DeCS descriptor for 'pharmaceutical care' in which it refers to the definition by Strand and Hepler. In the EMBASE database, the term 'pharmaceutical care' was included in 1994, with no definition provided but covering two aspects: the first one relating to medical procedures, therapy and pharmacotherapy; and the second one to the concepts of health care, health services, medical care. These findings should boost the attempts to include and unify the concept of PCAs and its definition in scientific literature databases.
This same difficulty was also identified by Melchior et al., who argue, as does this review, that the literature databases do not allow an easy and correct extraction of PC studies due to problems in indexing pharmacy practice studies, and they add that many of the items retrieved are not related to PC. 17 According to several
authors, there appears to be a decrease in the number of publications using the term 'PC', which has been replaced by medication therapy management (MTM) or pharmacotherapy follow-up. 10, 18, 19 This terminology change may be due to the influence of the health systems' characteristics, since for instance, in the USA, MTM is a health service that can be billed to Medicare which is based on pharmaceutical care. However, this variability reinforces the proposition of the American Pharmacists Association and the Canadian Society of Pharmaceutical Care of using a common language in order to facilitate the interaction with other health professions. 20, 21 In our review, more than half of the SR/MAs used various terms to describe PCAs. Despite such varied terminology, the results of this review indicate that the number of published SR/MAs tends to increase, which is expected due to the greater availability of original papers. However, given the heterogeneity of original studies, integrating their results into a later statistical analysis is not possible, so the number of MAs available in the literature is lower. This heterogeneity is a result of both the use of different concepts of PCAs and the existing differences among healthcare settings. While in hospital settings the interventions of PCAs are mostly centred on health professionals, ambulatory and community settings require a greater interaction of the pharmacist with the patients and their caregivers. These characteristics cause both the interventions and the outcomes evaluated in each case to differ. 10 The characterisation of the original studies included in the analysed SR/MAs shows that the use of quantitative methods predominates in PCA studies, maintaining the positivist approach that has prevailed in pharmacy schools. The search in fact did not filter the studies by design; further, no reviews containing qualitative studies were found, so supplementing quantitative studies with qualitative studies in the systematic reviews is highly recommended. 22 This result coincides with the findings of Oliveira et al. who found that only 0.6% of the PC studies published between 1997 and 2007 indexed in the MEDLINE database corresponded to qualitative research. Most of them mainly discussed the facilitating or complicating factors in the implementation of PC programs in an attempt to clarify the pharmacist's role in health sciences. 23 In this sense, emphasis is given to the need for further development of qualitative studies on PCAs, considering that medicines, besides being commodities or chemotherapeutic agents, are objects that have economic, social and anthropological dimensions [24] [25] [26] [27] and health is not a dichotomous state but a process in which health-disease-care are deeply related. [28] [29] [30] [31] The use of qualitative methods together with quantitative methods for carrying out research on PCAs shall supplement what has been learned so far and expand society's vision toward a social recognition of pharmacists.
The predominance of SR/MAs on adult and elderly patients can be explained by the higher incidence of chronic diseases in these age groups, which results in a greater frequency of medication use, and with ageing comes a higher frequency of polymedication. Such characteristics lead these patients to require continuous follow-up in order to guarantee the effectiveness and safety of their pharmacological treatment. [32] [33] [34] [35] The results of this bibliometric analysis emphasise the need for further studies in the paediatric population, which may be considered a priority because of the inherent risks of the use of medicines in children given their particular physiological characteristics. [36] [37] [38] The number of original papers included in each SR/ MA was highly variable. The SR/MAs on PCAs in ambulatory settings included a larger number of original studies. We cannot explain these results.
The results of the quality evaluation of the SR/MAs (AMSTAR) 39 showed that none of the reviews fully complies with the 11 established criteria and that poor-to-moderate quality reviews predominate. The most frequent shortcomings were related to the quality of the information retrieved to formulate conclusions, and to the search in databases of 'grey literature' (i.e. not available to the public).
As for the other bibliometric indicators analysed, the third part of the studies was done in a collaborative way. However, this collaboration was not consistent as often times it involved only one of the health professionals (physician or nurse) and rarely the three of them (physician, nurse and pharmacist). These results reflect Allemann et al.'s findings, since in only two of the 19 PC definitions found by them, PC was described as a collaborative activity, 9 and specifically in the definition of pharmacotherapy follow-up it was mentioned that PC must be performed in collaboration with the other health professionals. 40 Moreover, the authors' most frequent countries of origin (USA, UK, Australia and Canada) are countries where further development of pharmaceutical services has been documented. 20, [41] [42] [43] These results coincide with the large amount of publications in the English language. Latin America is represented by Brazil, which has the largest amount of publications on health issues. [44] [45] [46] However, the obtained results drew attention to Spain, a country with a recognised tradition in pharmaceutical care, several leading universities in the area and many publications in the Spanish language, 41, 47, 48 which was represented in this review by only a very small percentage.
The results also showed the significant research contribution of universities and public institutions, which reflects the scientific nature of this type of review and the professional interest in looking for evidence that demonstrates the impact of PCAs in health sciences.
Concerning the journals' scope and areas of interest, it was found that most of the SR/MAs were published in journals that do not specialise in the pharmacist profession area and with a very low impact factor.
The results of this review evidenced these four aspects that should be prioritised by researchers in the area of PCA in order to obtain better results: (i) to reach a consensus on the definition of PCAs to guarantee comparability of the results of the different studies; (ii) to establish minimum quality criteria for conducting studies on PCAs and apply the existing criteria for the development of SR/MAs, taking into account the contextual differences of each care setting; (iii) to incorporate qualitative methods in PCA studies, which would overcome the positivist view of the profession; and (iv) to carry out further research on PCAs in the paediatric population. The development of these aspects will enable an efficient use of resources, avoid duplication of efforts and generate higher-quality information on the effects of PCAs in practice.
Limitations
As there is no standardised way of grouping study variables (interventions, clinical problems, intervened population and professional teams) and most studies do not clearly describe them, we defined some categories for those variables even though they do not necessarily reflect the individuality of the reviews. Furthermore, the analysis was based on a number of inferences because of: the inappropriate use of the term 'pharmaceutical care'; poor quality of abstracts and indexed terms in the retrieving systems; and the lack of a description of the pharmaceutical care process in the method sections in many articles.
